Related Experiment Video
Updated: Oct 11, 2025

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Urotensin-II As a Promising Key-Point of Cardiovascular Disturbances Sequel
Ashot Avagimyan1, Albina Kajaia2, Luiza Gabunia2
1Department of Pathological Anatomy and Clinical Morphology, Yerevan State Medical University after M. Heratsi, Republic of Armenia.
Insights
Uncontrolled arterial hypertension is a major medical challenge. This study proposes urotensin II as a novel therapeutic target for managing hypertension, reflecting international medical perspectives.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Arterial hypertension remains a critical global health issue with persistent challenges in blood pressure control.
- The increasing prevalence of uncontrolled arterial hypertension necessitates novel therapeutic strategies.
- Understanding the intricate mechanisms underlying hypertension development and progression is a key focus in cardiovascular research.
Purpose of the Study:
- To introduce urotensin II as a potential new therapeutic target in the pathogenesis of arterial hypertension.
- To present a unified concept from Armenian, Georgian, and Iranian medical schools regarding urotensin II's role in hypertension.
- To explore the mechanisms by which urotensin II influences blood pressure regulation.
Main Methods:
- Literature review and synthesis of existing research on urotensin II and arterial hypertension.
- Multidisciplinary expert consensus building among international working groups.
- Analysis of preclinical and clinical data related to urotensin II pathways.
Main Results:
- Urotensin II is implicated as a significant factor in the development and progression of arterial hypertension.
- Evidence suggests urotensin II plays a role in vascular tone regulation and endothelial function.
- The study highlights potential for targeting urotensin II pathways for improved hypertension management.
Conclusions:
- Urotensin II represents a promising novel therapeutic target for arterial hypertension.
- Further research into urotensin II's role could lead to innovative treatment approaches.
- This collaborative work integrates diverse medical insights into a cohesive understanding of urotensin II in hypertension.
Abstract:
Arterial hypertension is a highly urgent problem of modern medicine since the crisis of blood pressure control remains open, due to the increasing number of uncontrolled arterial hypertension. Today, one of the most critical problems of cardiology is the study of the mechanisms of development and progression of arterial hypertension. Therefore, our international and multidisciplinary working group presents a vision of a new therapeutic target - urotensin II in the pathogenesis of arterial hypertension. Thus, this article reflects the concept of the Armenian, Georgian and Iranian medical schools.
Related Concept Videos
Hypertension II: Pathophysiology
Heart Failure II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hormonal Regulation

